LSV ASSET MANAGEMENT 13D and 13G filings for Ironwood Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-09 3:12 pm Sale | 2023-12-31 | 13G | Ironwood Pharmaceuticals, Inc. IRWD | LSV ASSET MANAGEMENT | 6,793,701 4.350% | -1,132,696 (-14.29%) | Filing |
| 2023-02-10 4:16 pm Purchase | 2022-12-31 | 13G | Ironwood Pharmaceuticals, Inc. IRWD | LSV ASSET MANAGEMENT | 7,926,397 5.170% | 7,926,397 (New Position) | Filing |